Latest S-1 registration statements

Loar Holdings Inc. files an S-1 registration statement detailing a voting agreement among key shareholders and its transition to a controlled company post-IPO.

Volato Group, Inc. has filed an amendment to its Form S-1 registration statement, detailing the potential offer and sale of up to 23,318,122 shares of common stock and 15,226,000 warrants by selling stockholders.

Soligenix, Inc. plans to raise up to $10 million through a public offering of common stock and warrants to fund research, development, and general corporate purposes.

Pinstripes Holdings, Inc. files an amendment to its Form S-1 registration statement related to the issuance and resale of common stock and warrants.

Worksport Ltd. has filed a registration statement for the resale of up to 7,700,264 shares of common stock issuable upon the exercise of outstanding warrants.

QT Imaging Holdings aims to raise capital through the potential sale of common stock and warrants, as detailed in its S-1 filing.

UL Solutions Inc. establishes a long-term incentive plan, granting restricted stock units to non-employee directors to align their interests with the company's long-term performance.

AEON Biopharma files for a potential $357 million resale of common stock and warrants, while also eyeing potential capital from warrant exercises.

Mobix Labs amends its business combination agreement to address option and warrant conversions and files an S-1 registration statement for a potential $100 million stock offering with B. Riley Principal Capital II.

Pinstripes Holdings files an updated S-1 registration statement to address SEC comments and register shares for warrant exercise and resale by selling securityholders.

Rubrik, Inc. prepares for its initial public offering by amending and restating its investors' rights agreement, detailing registration rights, covenants, and other key provisions.

PACS Group, Inc. files an amendment to its S-1 registration statement, detailing changes to its bylaws and confirming its application to list on the NYSE under the ticker symbol 'PACS'.

Kenilworth Systems Corporation has filed a registration statement for the resale of up to 25,531,228 shares of its common stock by selling stockholders.

American Bear Logistics Corp. secures a warehouse lease in Southlake, Texas, while simultaneously preparing for a potential initial public offering.

Microbot Medical has filed an amendment to its Form S-1 registration statement, pertaining to the resale of up to 1,005,965 shares of its common stock by selling stockholders, primarily related to the settlement of a lawsuit.

Contineum Therapeutics, a clinical-stage biopharmaceutical company, is seeking to raise approximately $150 million through an initial public offering to advance its pipeline of therapies for neuroscience, inflammation, and immunology indications.

Calidi Biotherapeutics plans to offer common stock units and pre-funded warrant units to raise capital.

Richtech Robotics has filed an amendment to its S-1 registration statement, outlining the potential resale of up to 12,983,208 shares of Class B common stock by YA II PN, Ltd. following a standby equity purchase agreement.

Panbela Therapeutics is registering the resale of up to 255,600 shares of its common stock by selling securityholders, while facing challenges with Nasdaq listing compliance.

CleanCore Solutions, Inc. files Amendment No. 7 to its Form S-1 registration statement, primarily to include updated exhibits.

Aptevo Therapeutics is launching a public offering of common stock and warrants to raise capital for clinical programs and general corporate purposes.

Acurx Pharmaceuticals is offering 12,019,230 shares of common stock to raise approximately $22.9 million for working capital and clinical trials.

Lenz Therapeutics registers for the resale of 1,297,411 shares of common stock issued in a PIPE financing following its merger with Graphite Bio.

Tivic Health Systems is seeking to raise capital through a best efforts offering of common stock and warrants to fund working capital and general corporate purposes.

Nascent Biotech aims to raise capital for Phase 2 clinical trials and administrative expenses through a stock offering involving the sale and resale of common stock and warrants.

PHI Group, a leading provider of flight services for the oil and gas and air medical industries, has filed an S-1/A form for an initial public offering, seeking to fund growth and general corporate purposes.

Cheetah Net Supply Chain Service Inc. aims to raise capital through a public offering of Class A common stock to fund working capital and expand warehousing and logistics services.

Know Labs has filed a registration statement for the potential resale of up to 10.8 million shares of its common stock by a selling stockholder.

Bitwise is seeking SEC approval for its Ethereum ETF, aiming to provide investors with exposure to ether through a regulated investment vehicle.

Skye Bioscience registers for the potential resale of up to 33.7 million shares of common stock by selling securityholders following a merger and several private placements.